The Pharmacometrics Landscape

Orienting yourself across the broader modeling approaches used in modern pharmacometrics

A high-level guide to the broader PMx landscape, including pharmacodynamics, disease progression, time-to-event models, PBPK, TMDD, QSP, and Bayesian approaches.

Welcome

So far, this course has focused on the core logic of pharmacometrics:

  • how PK data behave
  • how models are built and evaluated
  • how exposure connects to decisions

Now we step back and look at the broader field.

This module is not about mastering every specialized modeling framework.

Instead, it helps you answer:

What else exists in pharmacometrics, and how does it connect to what I already know?

Why this module matters

By this point, you already understand the core PMx workflow:

  • data → model → evaluation → decision

But the pharmacometrics landscape is much larger than:

  • compartment models
  • NCA
  • population PK
  • exposure-based decisions

This broader landscape includes models that focus on:

  • biological effect
  • event timing
  • disease change over time
  • physiological realism
  • systems biology
  • prior knowledge and probabilistic inference
Warning

This module is intentionally broad, not deep.
The goal is orientation and conceptual clarity—not full technical mastery.

Learning objectives

By the end of this module, you will be able to:

  • Explain where pharmacodynamics fits relative to pharmacokinetics
  • Recognize how time-to-event and disease progression models extend PMx thinking
  • Distinguish TMDD, PBPK, and QSP at a high level
  • Understand where Bayesian approaches fit into the field
  • See how these approaches connect back to the core ideas from the course

Course structure

This module provides a guided tour of the broader PMx landscape:

  1. Pharmacodynamics: From Exposure to Effect
    • Moving from concentration to biological response
    • Extending exposure–response into PD thinking
  2. Time-to-Event and Disease Progression Models
    • Modeling when events happen
    • Modeling how disease evolves over time
  3. Nonlinear PK, TMDD, and PBPK
    • When simple PK assumptions break
    • Mechanistic extensions beyond standard compartment models
  4. QSP and Bayesian Inference
    • Systems-level models
    • Probabilistic reasoning and prior information

Key idea

The goal of this module is not to turn every learner into an expert in every framework.

It is to help you understand:

what each approach is for, when it becomes useful, and how it relates to the core PMx ideas you already know

That way, when you encounter these terms in papers, teams, or future courses, they feel connected rather than unfamiliar.

What you’ll be able to do after this module

  • Place specialized PMx approaches into a coherent mental map
  • Distinguish “core PMx” from more specialized extensions
  • Recognize which advanced approaches are most relevant to different questions
  • Decide what areas you may want to study more deeply next

How this connects to the course ending

After this module, the course closes with:

Where to Go Next

That final section helps you decide how to continue your learning path—whether into:

  • coding and implementation
  • NCA in practice
  • population modeling
  • PBPK, PD, or Bayesian methods
  • more advanced pharmacometric workflows

Get started

Begin with Pharmacodynamics: From Exposure to Effect to see how pharmacometrics extends from concentration to biological response.